HOME >> BIOLOGY >> NEWS
Identification of genetic risk factor for coeliac disease promises improved treatment

An international research consortium investigating the genetic causes of intestinal inflammatory conditions has identified a new genetic risk factor for coeliac disease. The findings, published online today (10 June 2007) in the science journal Nature Genetics, could pave the way towards improved diagnostics and treatments for the common, lifelong complaint.

Led by David van Heel, Professor of Gastrointestinal Genetics at Queen Mary, University of London, the study - funded by the charity Coeliac UK, and the Wellcome Trust - has revealed that those suffering from coeliac disease lack a protective DNA sequence in a specific gene region, otherwise found in healthy individuals.

Behind the success of the study are the Human Genome Project and the Hap Map Project, international research efforts to reveal the entire sequence of all the human chromosomes - and the functional units embedded within - and to correlate that information to common sequence variation in the human population.

Dr Panos Deloukas, Senior Investigator in Human Genetics at the Wellcome Trust Sanger Institute, and part of the research consortium, said: These resources coupled with technological advances have enabled us to scan variation across the human genome in large numbers of people for association to disease. The Sanger Institute made available to the study the genome data on 1500 British individuals used as controls (i.e without coeliac disease). The consortium studied over four thousand individuals with and without coeliac disease, amongst British, Irish and Dutch populations.

What they found is that healthy individuals more often have a protective DNA sequence in the interleukin-2 and interleukin-21 gene region than individuals with coeliac disease. Interleukin-2 and interleukin-21 are cytokine proteins secreted by white blood cells that control inflammation. It is likely that the protective DNA sequence leads to different amounts of these cytokin
'"/>

Contact: Alex Fernandes
a.fernandes@qmul.ac.uk
020-788-27910
Queen Mary, University of London
10-Jun-2007


Page: 1 2

Related biology news :

1. Identification of carbon dioxide receptors in insects may help fight infectious disease
2. Identification of a protein important for Hepatitis B replication
3. Identification of specific genes predicts which patients will respond to Hepatitis C treatment
4. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
5. Does the desire to consume alcohol and tobacco come from our genetic makeup?
6. Almac Diagnostics announces pioneering genetic research on ductal carcinoma in situ
7. Penn researchers discover pathway that eliminates genetic defects in red blood cells
8. Identifying the mechanism behind a genetic susceptibility to type 2 diabetes
9. After a decades-long search, scientists identify new genetic risk factors for multiple sclerosis
10. Discoverer of Sly Syndrome finds way of delivering medicine to fight rare genetic disorder
11. Identified main genetic variants involved in response to HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/11/2020)... (PRWEB) , ... February 11, ... ... dedicated to solving complex problems for life sciences companies and government agencies, ... 30 years of management consulting expertise to Tunnell, with significant experience assessing, ...
(Date:2/6/2020)... ... 06, 2020 , ... Kerafast Inc. , developers of ... announced an agreement with The Good Food Institute , a nonprofit organization ... partnership, terrestrial meat and aquatic cell lines will be made available to scientists ...
(Date:1/29/2020)... , ... January 29, 2020 , ... ... the new Analytics and Data Sciences practice, providing consulting services for strategy, research ... was announced by Mike Townley, co-founder and Managing Partner of CREO, an innovative ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... 21, 2020 , ... Microbial Discovery Group LLC (MDG) is ... and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with ... 30 years of sales experience working across multiple different market sectors such as; ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... vendor qualification process, a critical element of clinical trial set up and execution. ... vendor qualification process creates delays in initiation in 7% of clinical trials for ...
(Date:1/8/2020)... SHREWSBURY, Mass. (PRWEB) , ... January 08, 2020 ... ... engineered clad metal wire composites that can achieve specific properties for use in ... Composite Clad Metal Wire combines up to three metals or alloys to ...
(Date:1/7/2020)... N.J. (PRWEB) , ... January 07, 2020 , ... Vuja ... prevent cancer progression and recurrence, today announced the appointments of Chand Khanna, DVM, PhD, ... Co-founder and CEO of Vuja De said, “We are delighted to welcome Chand and ...
Breaking Biology Technology:
Cached News: